{
    "medicine_id": "c766531ac9c9cf16aaad5cffa0a26ac7ca77bc66",
    "platform_id": "DB06693",
    "metadata": {
        "name": "Artiss 2 IU ml Solution",
        "composition": "2 IU ml Mevastatin",
        "clinical_particulars": {
            "therapeutic_indications": "Not used therapeutically due to its many side effects",
            "contraindications": {
                "disease": "Side effects include those of other statins such as myalgias abdominal pain nausea It also has a higher chance of giving more severe side effects related to myotoxicity myopathy myositis rhabdomyolysis and hepatotoxicity than other statins Due to these major side effects and their enhanced rate of occurance Mevastatin is not given therapeutically",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The primary cause of cardiovascular disease is atherosclerotic plaque formation Mevastatin lowers hepatic production of cholesterol to reduce the risk of cardiovascular disease Mevastatin competitively inhibits HMG CoA reductase This inhibition prevents the rate limiting step in cholesterol synthesis Decreased hepatic cholesterol levels causes increased uptake of low density lipoprotein LDL cholesterol and reduces cholesterol levels in the circulation",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09055",
                        "description": "Acipimox may increase the myopathic rhabdomyolysis activities of Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "Bezafibrate may increase the myopathic rhabdomyolysis activities of Mevastatin"
                    },
                    {
                        "drugbank-id": "DB09064",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ciprofibrate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "Colchicine may increase the myopathic rhabdomyolysis activities of Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "The risk or severity of myopathy can be increased when Mevastatin is combined with Daptomycin"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The risk or severity of rhabdomyolysis myoglobinuria and elevated creatine kinase CPK can be increased when Gemfibrozil is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "Mevastatin may increase the hepatotoxic activities of Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Mevastatin is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Mevastatin can be increased when combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01406",
                        "description": "The serum concentration of Mevastatin can be increased when it is combined with Danazol"
                    },
                    {
                        "drugbank-id": "DB00375",
                        "description": "Colestipol can cause a decrease in the absorption of Mevastatin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00658",
                        "description": "Sevelamer can cause a decrease in the absorption of Mevastatin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00930",
                        "description": "Colesevelam can cause a decrease in the absorption of Mevastatin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01432",
                        "description": "Cholestyramine can cause a decrease in the absorption of Mevastatin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The risk or severity of rhabdomyolysis can be increased when Fusidic acid is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB08983",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Etofibrate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13433",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Simfibrate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13460",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Ronifibrate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13780",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Aluminium clofibrate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13849",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibride is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB06792",
                        "description": "The absorption of Mevastatin can be decreased when combined with Lanthanum carbonate"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The metabolism of Mevastatin can be decreased when combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB09270",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Mevastatin can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Leuprolide is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00052",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Somatotropin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Infliximab is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cyclosporine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Pravastatin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Baclofen is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Sildenafil is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Indinavir is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lovastatin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cladribine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Phenytoin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Pamidronic acid is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mefloquine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Tacrine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Carbimazole is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cerivastatin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Trimethoprim is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Betamethasone is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Montelukast is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Zidovudine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cimetidine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ritonavir is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lercanidipine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ciprofloxacin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Vincristine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Propylthiouracil is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Methotrexate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Enalapril is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nizatidine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ivermectin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Chloroquine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Triamcinolone is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Alendronic acid is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Simvastatin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Stavudine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00666",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Amphotericin B is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mycophenolate mofetil is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lamivudine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ibandronate is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Propofol is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Terbinafine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Penicillamine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ranitidine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Tacrolimus is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Eprosartan is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Risedronic acid is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Bumetanide is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Triazolam is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ethanol is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Salmeterol is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Isoniazid is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Methyldopa is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Isotretinoin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cytarabine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ganciclovir is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01006",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Letrozole is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Sulfamethoxazole is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Minocycline is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Procainamide is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Norfloxacin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Atorvastatin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Iloprost is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Fluvastatin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Leflunomide is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Rosuvastatin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ofloxacin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Procarbazine is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Captopril is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Paclitaxel is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Saquinavir is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Metoclopramide is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Dexamethasone is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Docetaxel is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mevastatin is combined with Pitavastatin"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mevastatin is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mevastatin is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mevastatin is combined with Ipecac"
                    },
                    {
                        "drugbank-id": "DB13393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mevastatin is combined with Emetine"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Metformin may increase the hypolipidaemic activities of Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The therapeutic efficacy of Dicoumarol can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The therapeutic efficacy of Phenindione can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The therapeutic efficacy of Warfarin can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The therapeutic efficacy of 4 hydroxycoumarin can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The therapeutic efficacy of Coumarin can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The therapeutic efficacy of R warfarin can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The therapeutic efficacy of Fluindione can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The therapeutic efficacy of Clorindione can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The therapeutic efficacy of Diphenadione can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The therapeutic efficacy of Tioclomarol can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The therapeutic efficacy of S Warfarin can be increased when used in combination with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The serum concentration of Mevastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Mevastatin can be increased when it is combined with Lonafarnib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}